Prospective study of health-related quality of life in men with high- and intermediate-risk prostate cancer who received secondary therapy.

5054Background: Men with high risk (HR) and intermediate risk (IR) prostate cancer (CaP) require definitive therapy and may require secondary therapy (2*T) after primary treatment (1*T). Study aims...